Amazon Launches Comprehensive GLP-1 Management Program
Amazon (AMZN) announced the launch of a comprehensive GLP-1 Management Program through Amazon One Medical that integrates primary care, pharmacy services, and virtual care options to help patients achieve lasting weight loss results. Amazon says its new program addresses these challenges by connecting GLP-1 management with primary care and Amazon Pharmacy in one place, adding that the new program integrates GLP-1 management into patients' broader primary care relationship, proactively managing how weight loss intersects with cardiovascular health, metabolic conditions, and overall health. The program is available now at Amazon One Medical locations across the U.S. Amazon Pharmacy said it now offers the newly FDA-approved Wegovy and Foundayo oral GLP-1 pills for weight management, with insurance coverage starting as low as $25 per month or cash-pay options starting at $149 per month for both oral medications. Amazon Pharmacy also provides Wegovy injectables, Zepbound auto-injector, and KwikPen-a multi-dose injectable delivering a full month of medication in a single device, with cash-pay pricing starting at $299 per month. All medications are available for fast delivery to all 50 states, with Same-Day Delivery to nearly 3,000 cities and towns today and expanding to nearly 4,500 by the end of 2026. The Fly notes that shares of Hims & Hers (HIMS), which sells peptide-based products, are down 6.3% in premarket trading.
Trade with 70% Backtested Accuracy
Analyst Views on AMZN
About AMZN
About the author

- Cloud Growth Expectations: Bank of America raised Amazon's price target to $298, anticipating a 28% annual growth rate for Amazon Web Services (AWS), which exceeds market expectations and highlights strong demand and potential profitability in the cloud computing sector.
- AI Demand Driving Revenue: With surging demand for AI services from companies like Anthropic, AWS is projected to generate over $1 billion in a single quarter, reflecting the rapid growth of AI workloads on cloud platforms.
- Short-Term Profit Pressures: Despite strong demand for AI-related services, there may be short-term profit pressures, particularly as corporate infrastructure spending increases, prompting Amazon to implement cost-cutting measures, including layoffs, to mitigate these challenges.
- Overall Business Performance: Internal data indicates a slight increase in internet spending compared to the previous quarter, which is expected to boost overall revenue, suggesting that Amazon's core business outside of AWS is also experiencing steady growth.

- Amazon's Stock Performance: Amazon shares have increased by 1.7% following recent developments.
- Investment in Anthropic: The company has invested up to $25 billion in Anthropic, indicating a significant commitment to AI technology.

Amazon's Stock Performance: Amazon shares increased by 2.9% in pre-market trading.
Investment Announcement: The rise follows an announcement of a significant investment of up to $25 billion in an anthropic initiative.
- Massive Investment Plan: Anthropic announced plans to invest over $100 billion in cloud technology over the next decade, a move that will significantly enhance its technological capabilities and drive business growth.
- Cloud Technology Strategy: This investment will focus on strengthening its cloud infrastructure, aiming to improve service quality and customer experience, thereby positioning itself more favorably in a competitive market.
- Market Impact: As demand for cloud computing continues to rise, this investment by Anthropic is expected to not only propel its own technological advancements but also have a profound impact on the industry, fostering innovation and development in related technologies.
- Long-term Vision: Through this strategic investment, Anthropic aims to become a leader in the cloud technology space over the next decade, further solidifying its market position in artificial intelligence and machine learning.
- Valmont Industries Strong Performance: The agricultural products and infrastructure company saw its stock rise 12% after reporting better-than-expected first-quarter results, driven by strong demand in its North American utility business, while also raising the lower end of its full-year earnings guidance, indicating market confidence in future growth.
- Pitney Bowes Revenue Beat: Mailing equipment and services giant Pitney Bowes reported first-quarter revenue of $477 million, exceeding the market consensus of $465.9 million, leading to an 8% stock increase, which reflects the company's solid performance in a competitive market.
- UnitedHealth Earnings Surprise: UnitedHealth reported first-quarter earnings of $7.23 per share and revenue of $11.72 billion, both surpassing analyst expectations, resulting in a 9% stock increase, while the company also raised its full-year earnings outlook, showcasing its strong market position.
- Quest Diagnostics Strong Results: Laboratory testing services company Quest Diagnostics posted first-quarter earnings of $2.50 per share, exceeding the expected $2.37, with revenue reaching $2.90 billion, surpassing the $2.83 billion consensus estimate, leading to a 5.2% stock increase, highlighting its competitive edge in the industry.
- Tariff Refund Policy: Trump stated he will 'remember' companies that do not seek refunds, implying these firms might receive government support in the future, thereby influencing corporate refund decisions and their relationship with the government.
- Refund System Launch: The U.S. Customs and Border Protection (CBP) launched the CAPE refund processing system on Monday, expected to handle up to $166 billion in refund applications, although payments are not anticipated until 60 to 90 days post-application acceptance.
- Legal Action Dynamics: Major companies like Costco and FedEx have sued the U.S. government to secure timely tariff refunds, while Walmart and Amazon have refrained from litigation, possibly to avoid negative attention from Trump.
- Future Tariff Plans: Trump mentioned that the alternative tariffs being developed could yield higher revenue but will be more complex to implement, with these new tariffs not expected to take effect until July, potentially impacting corporate financial planning.








